Mechanisms by Which Influenza A Protects Against Asthma
甲型流感预防哮喘的机制
基本信息
- 批准号:7449665
- 负责人:
- 金额:$ 43.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-15 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAllergensAntigensAsthmaBreathingCaliforniaCell physiologyCellsDendritic CellsDevelopmentDisease ProgressionDoctor of PhilosophyEnvironmentExposure toGoalsImmune responseImmunityInfectionInfluenzaInfluenza A virusLaboratoriesLearningLungMusNumbersPersonal SatisfactionPhenotypePneumoniaPopulationPositioning AttributeReagentRoleSuppressor-Effector T-LymphocytesSystemT-Cell ActivationT-LymphocyteTransgenic MiceUniversitiesVirus DiseasesWeekairway hyperresponsivenessairway inflammationexperiencein vivoinfluenzaviruspreventpulmonary functionresearch studyrespiratoryresponsetool
项目摘要
DESCRIPTION (provided by applicant):
The overall goal of the proposed studies is to understand how infection with influenza A virus inhibits disease progression in asthma. Our hypothesis is that infection with influenza A virus alters the pulmonary environment and enhances the development of protective immune responses to allergens inhaled 2-4 weeks after infection. We believe that infection with influenza virus can in some situations promote "protective" immunity by the altering dendritic cell (DC) function in, and the cellular composition of the lungs, in a way that enhances the development of regulatory/suppressor cells, which inhibit the pulmonary bias towards Th2 sensitization, and which inhibit the development of airway hyperreactivity
(AHR), asthma exacerbations and disease progression.
Our laboratory is well positioned to perform these studies, because we have examined allergen-induced AHR in mice for many years, and have acquired a large number of tools and reagents to study many parameters of airway inflammation. We have examined the role of pulmonary dendritic cells (DCs), including CD8alpha- and CD8alpha+ subsets of DCs, and antigen- specific CD4+ regulatory T cells in AHR, and have defined the parameters required for their development. In addition, we were the first to demonstrate a major role for NKT cells in the development of AHR, and have a large number of reagents to study NKT cells (CD1d tetramers, NKT cell deficient and NKT cell transgenic mice, and expertise to purify and adoptively transfer NKT cells). Finally, we have previously shown that infection with influenza A virus followed 2-4 wks later by respiratory exposure to allergen results in an immune response that protects against AHR. We now propose to examine how influenza A infection alters the function of pulmonary DCs, NKT cells and the development of regulatory T cells that inhibit AHR. Dr. Nicole Baumgarth, DVM, PhD, (University of California, Davis) has extensive experience in the study of influenza virus, and will assist us with these experiments.
By understanding the specific mechanisms by which influenza affects the lung, we will develop a much greater understanding of immune responses that protect against Th2 inflammation and pulmonary exacerbations. We will also learn more about regulatory mechanisms that affect airway inflammation, and how viral infections and the environment affect the development of asthma.
描述(由申请人提供):
拟议研究的总体目标是了解流感A病毒感染如何抑制哮喘中疾病进展。 我们的假设是,流感病毒感染会改变肺部环境,并增强感染后2-4周吸入过敏原的保护性免疫反应的发展。 我们认为,在某些情况下,流感病毒感染可以通过改变的树突状细胞(DC)功能和肺的细胞组成来促进“保护性”免疫,从而增强调节/抑制细胞的发展,从而抑制调节/抑制细胞的发展。肺部对Th2敏化的偏见,并抑制气道高反应性的发展
(AHR),哮喘加剧和疾病进展。
我们的实验室可以很好地进行这些研究,因为我们已经检查了多年的小鼠过敏原诱导的AHR,并且已经获得了大量工具和试剂来研究气道炎症的许多参数。 我们已经检查了肺树突状细胞(DC)的作用,包括DC的CD8Alpha-和cd8alpha+亚群,以及AHR中抗原 - 特异性CD4+调节T细胞,并定义了其发育所需的参数。 此外,我们是第一个证明NKT细胞在AHR发展中起主要作用的人,并且具有大量研究NKT细胞的试剂(CD1D四聚体,NKT细胞缺乏和NKT细胞转基因小鼠,以及用于纯化和纯化和纯化和纯化和专业知识继而转移NKT细胞)。 最后,我们先前已经表明,流感A病毒感染随后2-4周,呼吸道暴露于过敏原导致免疫反应可预防AHR。 现在,我们建议检查流感A感染如何改变肺DC,NKT细胞的功能以及抑制AHR的调节性T细胞的发展。 DVM博士(加利福尼亚大学戴维斯大学)的Nicole Baumgarth博士在流感病毒研究方面拥有丰富的经验,并将为我们提供这些实验。
通过了解流感影响肺部的特定机制,我们将对可以预防TH2炎症和肺部恶化的免疫反应有更大的了解。 我们还将了解更多有关影响气道炎症的调节机制,以及病毒感染和环境如何影响哮喘的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DALE T UMETSU其他文献
DALE T UMETSU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DALE T UMETSU', 18)}}的其他基金
Targeting innate lymphoid cells during influenza virus-induced asthma
在流感病毒诱发的哮喘期间靶向先天淋巴细胞
- 批准号:
8566307 - 财政年份:2012
- 资助金额:
$ 43.95万 - 项目类别:
Peanut Glycolipid Antigens Activate Natural Killer T Cells Causing Severe Allergy
花生糖脂抗原激活自然杀伤 T 细胞,导致严重过敏
- 批准号:
8044035 - 财政年份:2010
- 资助金额:
$ 43.95万 - 项目类别:
Peanut Glycolipid Antigens Activate Natural Killer T Cells Causing Severe Allergy
花生糖脂抗原激活自然杀伤 T 细胞,导致严重过敏
- 批准号:
7877661 - 财政年份:2010
- 资助金额:
$ 43.95万 - 项目类别:
NKT cells recognize and respond to microbes at mucosal surfaces
NKT 细胞识别粘膜表面的微生物并对其做出反应
- 批准号:
7706862 - 财政年份:2009
- 资助金额:
$ 43.95万 - 项目类别:
Recognition of microbes by NKT cells at the lung mucosal surface
肺粘膜表面NKT细胞对微生物的识别
- 批准号:
7822608 - 财政年份:2009
- 资助金额:
$ 43.95万 - 项目类别:
Recognition of microbes by NKT cells at the lung mucosal surface
肺粘膜表面NKT细胞对微生物的识别
- 批准号:
7935423 - 财政年份:2009
- 资助金额:
$ 43.95万 - 项目类别:
NKT cells recognize and respond to microbes at mucosal surfaces
NKT 细胞识别粘膜表面的微生物并对其做出反应
- 批准号:
7897764 - 财政年份:2009
- 资助金额:
$ 43.95万 - 项目类别:
Mechanisms by which Influenza A Protects Against Asthma
甲型流感预防哮喘的机制
- 批准号:
6913268 - 财政年份:2005
- 资助金额:
$ 43.95万 - 项目类别:
Mechanisms by Which Influenza A Protects Against Asthma
甲型流感预防哮喘的机制
- 批准号:
7185842 - 财政年份:2005
- 资助金额:
$ 43.95万 - 项目类别:
Mechanisms by Which Influenza A Protects Against Asthma
甲型流感预防哮喘的机制
- 批准号:
7107940 - 财政年份:2005
- 资助金额:
$ 43.95万 - 项目类别:
相似国自然基金
鱼类过敏原小清蛋白广谱性模拟抗原的精准构筑及构效关系研究
- 批准号:32372439
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
中药注射剂过敏原的在线高效分离-鉴定-半抗原/类过敏检测系统的建立和致敏形成机制的研究
- 批准号:81872834
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
对过敏原蛋白有亲和性的温敏性纳米水凝胶的制备及识别机理研究
- 批准号:21874009
- 批准年份:2018
- 资助金额:65.0 万元
- 项目类别:面上项目
IL-35依赖的免疫调节T细胞iT(R)35对抗原特异性记忆T细胞的抑制在过敏性哮喘特异性免疫治疗中的作用和机制研究
- 批准号:81700037
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
桦树花粉主要过敏原Bet v 1过敏原性形成的分子机制研究
- 批准号:81701588
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The nose-lung cross talk in upper respiratory virus infection induced asthma exacerbations
上呼吸道病毒感染引起的哮喘加重中的鼻肺交互作用
- 批准号:
10733754 - 财政年份:2023
- 资助金额:
$ 43.95万 - 项目类别:
Interplay of the T Cell Repertoire Development and Early Life Exposure on Incident Risk of Peanut Allergy
T 细胞库发育和生命早期接触对花生过敏事件风险的相互作用
- 批准号:
10742029 - 财政年份:2023
- 资助金额:
$ 43.95万 - 项目类别:
Developing RNA Vaccines to Treat Peanut Hypersensitivity
开发治疗花生过敏的 RNA 疫苗
- 批准号:
10570339 - 财政年份:2023
- 资助金额:
$ 43.95万 - 项目类别:
An immunotherapeutic IgY formulation against norovirus diarrhea
一种针对诺如病毒腹泻的免疫治疗 IgY 制剂
- 批准号:
10693530 - 财政年份:2023
- 资助金额:
$ 43.95万 - 项目类别:
Polymer-derived biomaterials for mRNA delivery to induce antigen-specific immune tolerance
用于 mRNA 递送以诱导抗原特异性免疫耐受的聚合物衍生生物材料
- 批准号:
10886168 - 财政年份:2023
- 资助金额:
$ 43.95万 - 项目类别: